Ishaan Pejavar Rao
About Ishaan Pejavar Rao
Ishaan Pejavar Rao has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Remidex Pharma Private Limited and Sanil Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Remidex Pharma Private Limited
U24231KA1981PTC004260
|
Director | 24 Oct 2018 | 1981 | Active |
Sanil Pharmaceuticals Private Limited
U24239KA1989PTC010426
|
Director | 24 Oct 2018 | 1989 | Active |
|
Ishaan Labs Private Limited
U24233KA1995PTC018262
|
Director | 24 Oct 2018 | 1995 | Active |
|
Surima Ventures Llp
ACL-6273
|
Designated Partner | 27 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Alleviative Health Solutions Private Limited
U21001KA2023PTC177073
|
Director | 08 Aug 2023 | 2023 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ishaan Pejavar Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ishaan Pejavar Rao
Ishaan Pejavar Rao has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Remidex Pharma Private Limited and Sanil Pharmaceuticals Private Limited. Formerly with 1 company. Engaged in General Business, Healthcare. Contributes to corporate operations.
Ishaan Pejavar Rao is associated with 4 companies as Director and Designated Partner.
Ishaan Pejavar Rao has expertise in General Business, Healthcare.
Ishaan Pejavar Rao has 7 years in corporate governance.